Cannabis Report
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

Not exactly.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 54
Posts 6,541
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion PR Newswire (Canada) - 6/18/2018 8:00:00 AM
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion PR Newswire (US) - 6/18/2018 8:00:00 AM
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops PR Newswire (Canada) - 6/14/2018 8:00:00 AM
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops PR Newswire (US) - 6/14/2018 8:00:00 AM
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins PR Newswire (US) - 6/12/2018 8:00:00 AM
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins PR Newswire (Canada) - 6/12/2018 8:00:00 AM
Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Valeant Pharmaceu... Business Wire - 6/8/2018 6:00:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 6/8/2018 5:15:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2018 5:17:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2018 5:07:42 PM
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redempti... PR Newswire (Canada) - 6/1/2018 4:15:00 PM
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redempti... PR Newswire (US) - 6/1/2018 4:15:00 PM
Salix To Highlight New Clinical Data During Digestive Disease Week PR Newswire (Canada) - 5/31/2018 8:30:00 AM
Salix To Highlight New Clinical Data During Digestive Disease Week PR Newswire (US) - 5/31/2018 8:30:00 AM
Ex-Valeant Executive Convicted In Scheme -- WSJ Dow Jones News - 5/23/2018 3:02:00 AM
Former Valeant Executive Found Guilty on Charges Related to Kickback Scheme Dow Jones News - 5/22/2018 1:48:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2018 5:06:09 PM
Valeant Announces Pricing Of Private Offering Of Notes PR Newswire (Canada) - 5/17/2018 5:00:00 PM
Valeant Announces Pricing Of Private Offering Of Notes PR Newswire (US) - 5/17/2018 5:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2018 4:45:09 PM
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans PR Newswire (Canada) - 5/17/2018 7:15:00 AM
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans PR Newswire (US) - 5/17/2018 7:15:00 AM
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference PR Newswire (Canada) - 5/15/2018 8:00:00 AM
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference PR Newswire (US) - 5/15/2018 8:00:00 AM
VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) ... PR Newswire (US) - 5/15/2018 7:49:00 AM
JLS   Thursday, 11/09/17 03:27:34 PM
Re: JohnCM post# 3858
Post # of 4538 
Not exactly.

VRX is my second largest holding. MU is my largest.

The horizontal lines on the right side of the chart below represent the true statistical Closing price distribution of VRX over the last 13 months. The price regions around the spikes should be considered as Sup/Res regions. You should note that VRX is currently trading (with high volume) above an SR region centered at about $15.40 (on a sucky day).

It appears that price is headed toward the next highest SR level around $17. I like to bring in extra income by selling Covered Calls (CCs), so I’ll be looking to see how VRX behaves as it approaches its next resistance level then decide If I should sell those overhead Calls.

FWIW, I never use stop-loss orders -- it’s too easy to get stopped out of a perfectly good position. IMO it’s better to sell CCs when one feels like putting in stop-loss orders and let the market decide whether or not to take the shares. At least you get paid to be taken out. And if you don’t want to be taken out, you can always roll the Calls out and up at relatively low cost.




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist